Featured News Image Research news | Aug 5 2026 Knight Initiative for Brain Resilience Aging brains welcome reinforcements from outside immune cells The discovery from an unusual team of computer scientists and pathologists overturns longstanding dogma – and could point the way toward new therapies for neurodegenerative disease Image Podcast episodes | Jul 30 2026 Wu Tsai Neurosciences Institute How brain imaging is transforming mental health We talk with psychiatrist Leanne Williams about how brain scans could revolutionize the diagnosis and treatment of psychiatric disorders Image Research news | Jul 17 2026 Stanford Medicine Breakdown of immune cells’ interaction is key driver in aging, study finds Two immune cell types’ contact plays a major role in aging, and blocking a hormone’s influence on one of those types halted mice’s age-associated decline in multiple organs Image Research news | Jun 24 2026 Knight Initiative for Brain Resilience Why do some cells die in ALS but not others? New Knight Initiative research identifies a molecular signature in vulnerable cells that could lead to treatments to promote ALS resilience Displaying 1 - 5 news posts of 5 Filter Sort by Newest to oldest Oldest to newest News Type Wu Tsai Neuro News Knight Initiative news Director's messages Research news Researcher profiles News Features Awards and honors Podcast episodes Press coverage Publications Research Theme NeuroHealth NeuroDiscovery Image Podcast episodes | Feb 15 2024 Wu Tsai Neurosciences Institute OCD and Ketamine This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time. Image Press coverage | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest. Image Podcast episodes | Jan 26 2023 Wu Tsai Neurosciences Institute Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?" Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Press coverage | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
Image Research news | Aug 5 2026 Knight Initiative for Brain Resilience Aging brains welcome reinforcements from outside immune cells The discovery from an unusual team of computer scientists and pathologists overturns longstanding dogma – and could point the way toward new therapies for neurodegenerative disease
Image Podcast episodes | Jul 30 2026 Wu Tsai Neurosciences Institute How brain imaging is transforming mental health We talk with psychiatrist Leanne Williams about how brain scans could revolutionize the diagnosis and treatment of psychiatric disorders
Image Research news | Jul 17 2026 Stanford Medicine Breakdown of immune cells’ interaction is key driver in aging, study finds Two immune cell types’ contact plays a major role in aging, and blocking a hormone’s influence on one of those types halted mice’s age-associated decline in multiple organs
Image Research news | Jun 24 2026 Knight Initiative for Brain Resilience Why do some cells die in ALS but not others? New Knight Initiative research identifies a molecular signature in vulnerable cells that could lead to treatments to promote ALS resilience
Image Podcast episodes | Feb 15 2024 Wu Tsai Neurosciences Institute OCD and Ketamine This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time.
Image Press coverage | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest.
Image Podcast episodes | Jan 26 2023 Wu Tsai Neurosciences Institute Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?"
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Press coverage | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
